Table 4.
Effect on endometrium after treatment
| Endometrium | Before treatment (n = 36) | After treatment (n = 33) at 6 month |
|---|---|---|
| Normal | 35 (97 %) | 3 (9 %) |
| Atrophic | – | 2 (6 %) |
| Disordered proliferative | 1 (3 %) | 26 (79 %) |
| Proliferative | – | 1 (3 %) |
| Hyperplasia | – | – |
| Simple hyperplasia | – | – |
| Complex hyperplasia without atypia | – | 2 (6 %)a |
aOne patient opted for surgical therapy and underwent a total abdominal hysterectomy at 9½ month after initiation of the drug. Second patient was put on tab. MPA 10 mg TDS at 6 month after initiation of Mifepristone and was kept on follow-up